US Stocks
/
OnKure Therapeutics, Inc. Class A Share Price
OnKure Therapeutics, Inc. Class A Share Price

OnKure Therapeutics, Inc. Class A Share Price

NASDAQ: OKUR | Micro Cap
$2.95
+0.00 (0.00%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

OnKure Therapeutics, Inc. Class A Stock Performance

Open
$2.96
Prev. Close
$2.95
Circuit Range
N/A
Day Range
$2.91 - $3.02
Year Range
$2.25 - $5.30
Volume
15,349
Average Traded
$2.96

OnKure Therapeutics, Inc. Class A Share Price Today

As of 19 September 2026, OnKure Therapeutics, Inc. Class A's share price is $2.95. The stock opened at $2.96, compared to its previous close of $2.95. During today's trading session, OnKure Therapeutics, Inc. Class A's share price traded between $2.91 and $3.02, with an average price of $2.97. Over the past 52 weeks, the stock has recorded a high of $5.30 and a low of $2.25. In terms of performance, OnKure Therapeutics, Inc. Class A's share price has declined by 28.40% over the last six months and is up 6.88% on a year-on-year basis.

OnKure Therapeutics, Inc. Class A Share Price Chart

$2.91$3.02
L
Show Current Price
H

OnKure Therapeutics, Inc. Class A Stock Fundamentals & Key Indicators

Market Cap
$39.87M
PE Ratio (TTM)
-0.67
Dividend Yield
N/A
EPS (TTM)
$-4.40
Revenue (TTM)
N/A
Return On Equity (TTM)
-105.93%
Profit Margin
N/A
Debt to Equity
0.11
Quarterly Earnings Growth YoY
-298.13%

OnKure Therapeutics, Inc. Class A Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$8.43M-$5.36M-$3.69M-$15.93M-$15.39M-$14.70M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A36.38%31.13%-331.34%3.36%4.49%

OnKure Therapeutics, Inc. Class A Annual Profit & Loss

All figures in USD

Particulars202220242025
RevenueN/AN/AN/A
Net Profit-$51.95M-$52.67M-$59.52M
Net Profit MarginN/AN/AN/A
Income ChangeN/A-1.38%-12.99%

About OnKure Therapeutics, Inc. Class A

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.

OnKure Therapeutics, Inc. Class A Historical Returns

MonthOpenCloseChange %
Sep 2026
$3.64
$2.95
-23.18%
Aug 2026
$3.78
$3.84
-0.13%
Jul 2026
$4.64
$3.85
-15.31%
Jun 2026
$4.46
$4.54
+7.84%
May 2026
$5.25
$4.21
-20.19%
Apr 2026
$4.12
$5.28
+28.03%
Mar 2026
$2.65
$4.12
+52.59%
Feb 2026
$2.66
$2.70
+1.31%
Jan 2026
$2.93
$2.67
-6.82%
Dec 2025
$2.94
$2.86
-4.51%
Nov 2025
$3.44
$3.00
-9.79%
Oct 2025
$2.73
$3.32
+20.29%

OKUR Share Price FAQs

What is OnKure Therapeutics, Inc. Class A share price today?

chevron-up
OnKure Therapeutics, Inc. Class A share price today is $2.95 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of OnKure Therapeutics, Inc. Class A stock?

chevron-up
The 52 week high of OnKure Therapeutics, Inc. Class A stock is $5.30, while the 52 week low is $2.25 as of 19 Sep '26.

What is OKUR's market capitalisation today?

chevron-up
OKUR market capitalisation is $39.87M as of September 19, 2026, at 8:37 pm IST.

What is OKUR's net income for the last quarter?

chevron-up
OKUR's net income for the last quarter is -0.01B USD.

What is the 5 year returns of OKUR?

chevron-up
The 5 year returns of OKUR is -96.04% as on 19 Sep '26.

What is the high & low stock price of OKUR today?

chevron-up
OKUR stock price hit a high of $3.02 and low of $2.91 as of 19 Sep '26.

Can I buy OKUR shares in India?

chevron-up
Yes. You can buy OKUR in India by opening an international trading account.